Cookies?
Library Header Image
LSE Research Online LSE Library Services

Investments in research and development for supplemental drug indications: implications for drug price negotiations

Vokinger, Kerstin N., Perényi, Gellért and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Investments in research and development for supplemental drug indications: implications for drug price negotiations. JAMA Health Forum, 4 (9). E232798. ISSN 2689-0186

[img] Text (Investments in Research and Development for Supplemental Drug Indications —Implications for Drug Price Negotiations) - Published Version
Available under License Creative Commons Attribution.

Download (332kB)

Identification Number: 10.1001/jamahealthforum.2023.2798
Item Type: Article
Additional Information: © 2023 The Author(s)
Divisions: Health Policy
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
R Medicine
R Medicine > RM Therapeutics. Pharmacology
Date Deposited: 06 Jul 2023 13:09
Last Modified: 18 Apr 2024 15:36
URI: http://eprints.lse.ac.uk/id/eprint/119649

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics